Sector: MedicalPharmacyclics, Inc. (NASDAQ: PCYC)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 176 |
Technical : | 7 |
Performance : | 83 |
Overall: | 42 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 182 |
Technical : | 152 |
Performance : | 98 |
Overall: | 140 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 233 |
Technical : | 171 |
Performance : | 165 |
Overall: | 231 |
Number of Stocks: | 306 |
Headlines
- Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Nov 12, 2009 04:12 PM | PCYC
- Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009
Nov 09, 2009 09:03 AM | PCYC
- Pharmacyclics Reports First Quarter Fiscal 2010 Financial Results
Oct 29, 2009 04:58 PM | PCYC
- Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
Sep 17, 2009 04:00 PM | PCYC
- Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call
Sep 14, 2009 01:07 PM | PCYC
- Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences
Sep 03, 2009 02:30 PM | PCYC
- Six Stocks That Fit Short Selling Patterns
Sep 11, 2008 01:45 PM | APWR, DTG, PCYC
- Thirteen Penny Stocks That Are In Play
Sep 09, 2008 10:48 AM | CHCI, FNM, FRE, IDMI, PCYC, SNIC
- Eight Stocks which could be Setting Up
Sep 08, 2008 11:47 AM | DSL, FNM, FRE, PCYC, SIRF
- Just 18 Stocks To Watch Today!
Jun 09, 2008 11:45 AM | AAPL, CHP, END, INO, ISPH
- Pharmacyclics, Inc. Rights Offering Oversubscribed
Aug 05, 2009 08:02 AM | PCYC
- Pharmacyclics Announces Subscription Price for Rights Offering
Jul 15, 2009 08:50 PM | PCYC
- Pharmacyclics Sets Record Date for Rights Offering
Jul 07, 2009 01:28 PM | PCYC
- Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
Jun 05, 2009 02:15 PM | PCYC
- Pharmacyclics Files Registration Statement for Rights Offering
Jun 01, 2009 07:55 AM | PCYC
- Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
Apr 23, 2009 08:03 AM | PCYC
- Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
Apr 17, 2009 08:31 AM | PCYC
- Pharmacyclics Updates Positive Clinical Responses in its PCI-24781 Clinical Program Targeting HDAC
Apr 16, 2009 01:38 PM | PCYC
- Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
Apr 13, 2009 05:16 PM | PCYC
- Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
Mar 16, 2009 09:00 PM | PCYC
- Form 4 Buggy Joseph J For: Oct 30 (10K)
Nov 03, 2009 06:51 PM
- Form 4 Loury David J For: Oct 30 (10K)
Nov 03, 2009 06:51 PM
- Form 4 Hamdy Ahmed MD For: Oct 30 (10K)
Nov 03, 2009 06:51 PM
- Form 4 Rice Glenn C For: Oct 30 (10K)
Nov 03, 2009 06:51 PM
- Form 4 Erdtmann Rainer M For: Oct 30 (10K)
Nov 03, 2009 06:50 PM
- Form 4 Smith David Duane For: Oct 01 (10K)
Oct 05, 2009 07:48 PM
- Form 4 Bamdad Cynthia For: Oct 01 (10K)
Oct 05, 2009 07:47 PM
- Form 4 ADELMAN JASON T For: Oct 01 (10K)
Oct 05, 2009 07:40 PM
- Form 4 Smith David Duane For: Aug 05 (10K)
Aug 07, 2009 08:36 PM
- Form 4 Rice Glenn C For: Aug 05 (10K)
Aug 07, 2009 08:36 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PCYC
|
Compare to S&P
|
| YTD |
132.91 %
|
92.76 %
|
| 4 Weeks |
-1.08 %
|
-2.15 %
|
| 12 Weeks |
43.75 %
|
35.52 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 40.00 %
|
|
EPS Growth in Last Year: 52.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|